MENU
+Compare
ORGO
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$6.21
Change
-$0.27 (-4.17%)
Capitalization
789.39M

ORGO Organogenesis Holdings Forecast, Technical & Fundamental Analysis

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets... Show more

ORGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ORGO with price predictions
Nov 12, 2025

ORGO in upward trend: price rose above 50-day moving average on November 07, 2025

ORGO moved above its 50-day moving average on November 07, 2025 date and that indicates a change from a downward trend to an upward trend. In of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 07, 2025. You may want to consider a long position or call options on ORGO as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORGO just turned positive on November 07, 2025. Looking at past instances where ORGO's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ORGO crossed bullishly above the 50-day moving average on November 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where ORGO advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORGO broke above its upper Bollinger Band on November 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORGO entered a downward trend on November 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.094) is normal, around the industry mean (18.827). P/E Ratio (63.750) is within average values for comparable stocks, (71.764). ORGO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). ORGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (1.706) is also within normal values, averaging (39.291).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ORGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORGO is expected to report earnings to rise 30.40% to 15 cents per share on February 26

Organogenesis Holdings ORGO Stock Earnings Reports
Q4'25
Est.
$0.16
Q3'25
Beat
by $0.06
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.05
The last earnings report on November 06 showed earnings per share of 12 cents, beating the estimate of 6 cents. With 1.08M shares outstanding, the current market capitalization sits at 789.39M.
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIFGX12.49-0.04
-0.32%
MFS Diversified Income R4
IEGFX23.25-0.09
-0.39%
Invesco International Small Company R6
EAEMX17.63-0.07
-0.40%
Parametric Emerging Markets A
DFALX33.97-0.34
-0.99%
DFA Large Cap International I
AMRAX7.13-0.12
-1.66%
American Growth One A

ORGO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-0.31%
ANIP - ORGO
45%
Loosely correlated
-1.43%
ANIK - ORGO
36%
Loosely correlated
-0.30%
PRGO - ORGO
34%
Loosely correlated
-0.98%
ACET - ORGO
29%
Poorly correlated
+6.24%
AMPH - ORGO
27%
Poorly correlated
+2.47%
More

Groups containing ORGO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-0.31%
Pharmaceuticals: Generic
industry (214 stocks)
27%
Poorly correlated
-1.00%